Laguna Announces FDA Clearance of IND Application for LGNA-100, a Novel γδ T Cell Activator for High-Risk Pediatric Leukemias Notified -
ORBCOMM® refinances existing debt facility and secures capital to accelerate market leadership Notified -
Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined Execution Notified -
Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy Notified -
Boehringer Ingelheim and Eko Health Inc. launch new AI-based solution that detects heart murmurs in dogs Notified -
New Report from the MPA’s Content Security Initiative Links Control Failures to Content Security Incidents Across the Entertainment Industry Notified -
ETC’s Aerospace and Commercial/Industrial Units Awarded Contracts of Approximately $37 Million Notified -